EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiological and neurochemical correlates of the neurotoxic effects of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine on central catecholamine neurons in the mouse


Naunyn-Schmiedeberg's Archives of Pharmacology 331(1): 1-6
Electrophysiological and neurochemical correlates of the neurotoxic effects of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine on central catecholamine neurons in the mouse
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is an agent which produces a parkinsonian syndrome in man. To explore the use of MPTP in a rodent model of parkinsonism, male albino mice (NMRI) were given MPTP (50 mg/kg, s.c.) twice with a 6-8 h interval. Up to 10 weeks after injection, mice were killed and high-pressure liquid chromatography was used to assay dopamine (DA) and noradrenaline (NA) concentrations in various regions of the CNS. At 4 and 10 weeks after injection, DA levels were significantly reduced in occipital cortex (-40%), hippocampus (-30%), and striatum (-60%). NA levels were reduced by 60-80% in frontal and occipital cortex, hippocampus, and cerebellum. Neither DA nor NA concentration was reduced in spinal cord. Dopaminergic denervation was also suggested by electrophysiological data which showed that treatment with MPTP increased the spontaneous discharge rate of caudate neurons and decreased the potency of locally administered phencyclidine, an indirect DNA agonist. However, denervation was evidently not complete enough to produce postsynaptic receptor supersensitivity, as MPTP treatment did not increase the potency of locally applied DA, and it did not increase 3H-spiperone binding in striatal membrane preparations. These results suggest that MPTP causes regionally selective and long-term reductions of catecholamine transmission in the CNS of the mouse.


Accession: 005349450



Related references

Electrophysiological and neurochemical correlates of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse. Naunyn-Schmiedeberg's Archives of Pharmacology 331(1): 1-6, 1985

Neurochemical and histochemical characterization of neurotoxic effects of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine on brain catecholamine neurons in the mouse. Journal of Neurochemistry 44(1): 117-127, 1985

Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse. Journal of Neurochemistry 44(1): 117-127, 1985

Pharmacological interference with the neurotoxic action of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine on central catecholamine neurons in the mouse. European Journal of Pharmacology 110(3): 293-300, 1985

Neurotoxic effects of n methyl 4 phenyl 1 2 3 6 tetrahydropyridine on brain catecholamine neurons in the mouse. Neuroscience Letters (SUPPL 18): S202, 1984

Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse. European Journal of Pharmacology 110(3): 293-299, 1985

Monoamine oxidase and catecholamine uptake inhibition protect catecholamine neurons in mouse brain from the neurotoxic actions of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine. Journal of Neurochemistry 44(SUPPL): S183, 1985

Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures. Journal of Pharmacology and Experimental Therapeutics 253(2): 892-898, 1990

Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse. Neuroscience Letters 69(3): 285-289, 1986

Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse. European Journal of Pharmacology 97(1-2): 133-136, 1984